Galapagos NV
GLPG
#4522
Rank
C$3.11 B
Marketcap
C$47.25
Share price
1.08%
Change (1 day)
43.62%
Change (1 year)

Market capitalization of Galapagos NV (GLPG)

Market cap: C$3.11 Billion

As of February 2026 Galapagos NV has a market cap of C$3.11 Billion. This makes Galapagos NV the world's 4522th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Galapagos NV from 2008 to 2026

End of year Market Cap

Year Marketcap Change
2026C$3.11 B4.46%
2025C$2.98 B15.47%
2024C$2.58 B-27.34%
2023C$3.55 B-10.39%
2022C$3.96 B-14.84%
2021C$4.65 B-43.61%
2020C$8.25 B-53.21%
2019C$17.64 B158.07%
2018C$6.83 B13.23%
2017C$6.03 B50.78%
2016C$4.00 B17.11%
2015C$3.41 B416.31%
2014C$0.66 B-0.73%
2013C$0.66 B18.72%
2012C$0.56 B54.89%
2011C$0.36 B-14.68%
2010C$0.42 B58.56%
2009C$0.26 B114.65%
2008C$0.12 B

End of Day market cap according to different sources

On Feb 3rd, 2026 the market cap of Galapagos NV was reported to be:

C$3.11 Billion
by Nasdaq info icon info icon
C$3.11 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
C$766.97 B 24,531.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$259.13 B 8,222.00%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$544.67 B 17,392.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$157.52 B 4,959.04%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
C$395.15 B 12,590.28%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$780.48 B 24,965.21%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$147.22 B 4,628.10%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
C$0.13 B-95.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$56.79 B 1,724.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel